Cargando…
Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
Intratumor heterogeneity of colorectal cancers (CRCs) is manifested both at the genomic and epigenomic levels. Early genetic aberrations in carcinogenesis are clonal and present throughout the tumors, but less is known about the heterogeneity of the epigenetic CpG island methylator phenotype (CIMP)....
Autores principales: | Flatin, Bjørnar T.B., Vedeld, Hege Marie, Pinto, Rita, Langerud, Jonas, Lind, Guro E., Lothe, Ragnhild A., Sveen, Anita, Jeanmougin, Marine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898891/ https://www.ncbi.nlm.nih.gov/pubmed/33284993 http://dx.doi.org/10.1002/ijc.33425 |
Ejemplares similares
-
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
por: Vedeld, Hege Marie, et al.
Publicado: (2017) -
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
por: Kresse, Stine H., et al.
Publicado: (2023) -
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018) -
The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014) -
PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data
por: Jeanmougin, Marine, et al.
Publicado: (2022)